Growth hormone (GH) is a polypeptide hormone that could reduce the mitochondria-
mediated oxidative stress and improve the mitochondrial function. However, the …

Recent evidence has emphasized growth hormone benefits in increasing the ovarian
response and improving the pregnancy rate in poor responders (POR), caused by aging …

Optimisation of the environment favourable for satisfactory ovarian response to stimulation
and successful embryo implantation remains at the core of assisted conception …

Recently, three meta-analyses have concluded that cotreatment with GH improves assisted
reproduction outcome in poor controlled ovarian stimulation responders. Although generally …

Poor ovarian response (POR) often means low success rates after in vitro fertilisation (IVF).
We aim to study the impact of a low-dose growth hormone (GH) supplementation in …

Poor ovarian response is not infrequent and represents one of the major therapeutic
challenges in in vitro fertilization. Although several tests have been proposed, which aim at …

Growth hormone (GH) is involved in the regulation of male and female infertility. Several
clinical studies reveal that adjuvant GH treatment has a possible role in vitro fertilization …

Abstract 'Poor responders' is a term used to describe a subpopulation of IVF patients who do
not respond well to ovarian stimulation with gonadotrophins. While there is no standard …

Growth hormone (GH) has been used as a co-gonadotrophin in assisted reproduction,
particularly in poor ovarian responders. The application of GH has been alleged to activate …

Growth Hormone (GH) has been considered as a therapeutic option to increase the number
of growing follicles during Assisted Reproductive Technology (ART) for more than 30 years …